Pancreatic Cancer Research

ResearcherHeidelberg UniversityNo recent work listed

Tobias Förster

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5072077397. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

  1. Cetuximab in Pancreatic Cancer Therapy: A Systematic Review and Meta-Analysis. Co-author DOI 10.1159/000502844↗
  2. Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication. Co-author DOI 10.18632/oncotarget.1764↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pascal Probst · 1 shared paper, 2020 · strength 0.11
  2. Thilo Hackert · 1 shared paper, 2020 · strength 0.11
  3. Markus K. Diener · 1 shared paper, 2020 · strength 0.11
  4. Christoph Springfeld · 1 shared paper, 2020 · strength 0.11
  5. Matthias J. Löhr · 1 shared paper, 2020 · strength 0.11
  6. Clifford C. Nwaeburu · 1 shared paper, 2014 · strength 0.03
  7. Michael Schaefer · 1 shared paper, 2014 · strength 0.03
  8. Nathalia A. Giese · 1 shared paper, 2014 · strength 0.03
  9. Peter Schemmer · 1 shared paper, 2014 · strength 0.03
  10. Orkhan Isayev · 1 shared paper, 2014 · strength 0.03
  11. Li Liu · 1 shared paper, 2014 · strength 0.03
  12. Yiyao Zhang · 1 shared paper, 2014 · strength 0.03
  13. Jens Werner · 1 shared paper, 2014 · strength 0.03
  14. Ingrid Herr · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.